BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 19651630)

  • 1. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
    Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C
    Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase.
    Liu H; Luan F; Ju Y; Shen H; Gao L; Wang X; Liu S; Zhang L; Sun W; Ma C
    Biochem Biophys Res Commun; 2007 Apr; 355(2):379-84. PubMed ID: 17307151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
    Zhang X; Dong N; Zhang H; You J; Wang H; Ye L
    J Lab Clin Med; 2005 Feb; 145(2):98-104. PubMed ID: 15746653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes.
    Zhang X; Gao L; Liang X; Guo M; Wang R; Pan Y; Liu P; Zhang F; Guo C; Zhu F; Qu C; Ma C
    Liver Int; 2015 Mar; 35(3):1087-94. PubMed ID: 25047684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
    Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of preS2 antisense RNA on hepatocellular carcinoma with a novel delivery system.
    Ma C; Sun W; Tian P; Wang X; Liu S; Zhang L; Cao Y; Zhu F; Zhang Q
    Chin Med J (Engl); 2003 May; 116(5):717-20. PubMed ID: 12875688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
    Zhang PH; Zou L; Tu ZG
    J Surg Res; 2006 Mar; 131(1):143-9. PubMed ID: 16298398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
    Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
    Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
    Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase and c-myc expression in hepatocellular carcinomas.
    Liu YC; Chen CJ; Wu HS; Chan DC; Yu JC; Yang AH; Cheng YL; Lee SC; Harn HJ
    Eur J Surg Oncol; 2004 May; 30(4):384-90. PubMed ID: 15063891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner.
    Gai X; Zhao P; Pan Y; Shan H; Yue X; Du J; Zhang Z; Liu P; Ma H; Guo M; Yang X; Sun W; Gao L; Ma C; Liang X
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1174-85. PubMed ID: 23542016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.
    Liu P; Zhang H; Liang X; Ma H; Luan F; Wang B; Bai F; Gao L; Ma C
    Oncotarget; 2015 Oct; 6(30):29048-59. PubMed ID: 26315112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
    Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T
    Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53].
    Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Marukawa Y; Arai K; Yamashita T; Tsuji H; Kuzushima K; Takiguchi M; Kaneko S
    Hepatology; 2006 Jun; 43(6):1284-94. PubMed ID: 16729333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.